Related by context. Frequent words. (Click for all words.) 68 orally bioavailable 65 Voreloxin 65 DB# [003] 63 Bavituximab 63 humanized monoclonal antibody 63 tyrosine kinase inhibitor 63 Azedra 63 KNS # 62 Lenalidomide 62 BAY #-# 62 Debio 62 generation antisense 62 Bortezomib 62 GRN#L 61 Bevacizumab 61 Chrysalin 61 kinase inhibitor 61 ONX 61 CA4P 61 Linaclotide 61 Amrubicin 61 angiogenesis inhibitor 60 CR# vcMMAE 60 L Annamycin 60 Drug Candidate 60 MB# [004] 60 Irinotecan 60 Nexavar ® 60 synthetic peptide 60 AZD# 60 antisense drug 60 Maraviroc 60 Elesclomol 60 TG# [001] 60 HCV protease inhibitor 60 PRX# 60 HspE7 60 OXi# 59 integrase inhibitor 59 selective inhibitor 59 LY# [002] 59 humanized anti 59 drug conjugate 59 thymalfasin 59 Doxorubicin 59 MAP# 59 Phase 2a clinical 59 immunotherapeutics 59 Pivotal Phase 59 SGX# 59 Erlotinib 58 AVE# 58 CoFactor 58 Icatibant 58 potent inhibitor 58 DAVANAT 58 dacarbazine 58 NNRTIs 58 prodrugs 58 Aurora kinase 58 ISIS # 58 Perifosine 58 CG# [001] 58 PF # [001] 58 TELCYTA 58 VEGF Trap 58 Gemcitabine 58 VQD 58 MDV# 58 HGS ETR1 58 Avastin bevacizumab 58 Clinical Trial Results 58 Atiprimod 58 CYC# 58 photodynamic therapy PDT 58 Hycamtin 58 Phase 2b clinical 58 Nimotuzumab 58 Trastuzumab 58 Phase 2b trial 57 Phase IIa clinical 57 SCH # 57 therapeutic monoclonal antibodies 57 ADL# 57 PS# [001] 57 Fidaxomicin 57 RP# [002] 57 Torisel 57 partial agonist 57 Phase Ib 57 Synavive 57 Revimmune 57 injectable formulation 57 decitabine 57 immunomodulator 57 RG# [001] 57 diabetic neuropathic pain 57 Phase 2a trial 57 tezampanel 57 Preclinical studies 57 hypoxia inducible factor